title: Hot Topics in Primary Care: Sublingual Immunotherapy: A Guide for Primary Care.
abstract: Allergen immunotherapy (AIT), the only potential disease-modifying treatment for allergic disease, has been used for more than a century. Hankin et al showed significant reduction in pharmacy, outpatient, and inpatient resources in the 6 months following vs the 6 months preceding AIT in Medicaid-enrolled children with allergic rhinitis (AR). A 2013 analysis showed sustained cost reduction over 18 months in patients with AR treated with AIT compared with matched control subjects not treated with AIT.
authors.affiliation: Clinical Professor of Pediatrics, Division of Allergy and Immunology, University of California, San Diego, CA, USA.
authors.forename: Eli O
authors.initials: EO
authors.lastname: Meltzer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000191:economics / Q000592:standards*; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology* / Q000628:therapy*; D063729:Sublingual Immunotherapy / Q000191:economics* / Q000592:standards*; D014481:United States; D055815:Young Adult